Kailera Therapeutics, Inc. (KLRA)

17.72 +1.18 (+7.13%) USD  |  NASDAQ  |  Aug 25, 16:00
17.60 -0.12 (-0.68%) After-Hours: 19:12
More

Kailera Therapeutics Revenue Estimates for Current Fiscal Year

Revenue Estimates for Current Fiscal Year Chart

View Revenue Estimates for Current Fiscal Year for KLRA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Fiscal Year Chart
Start Trial

Historical Revenue Estimates for Current Fiscal Year Data

View and export this data back to 2026. Start Trial.
Date Value
August 13, 2026 --
August 12, 2026 --
July 07, 2026 --
Date Value
May 27, 2026 --
May 12, 2026 --

Revenue Estimates for Current Fiscal Year Range, Past 5 Years

View Revenue Estimates for Current Fiscal Year Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Fiscal Year Benchmarks

View Revenue Estimates for Current Fiscal Year Benchmarks
Start Trial
Moderna, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Sana Biotechnology, Inc. Upgrade
Parabilis Medicines, Inc. --
Arrowhead Pharmaceuticals, Inc. Upgrade

Revenue Estimates for Current Fiscal Year Related Metrics

EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade